Vancomycin-resistant Enterococcus: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Vancomycin-resistant Enterococcus | |||
| image = [[File:Vancomycin-Resistant_Enterococcus_01.jpg|250px]] | |||
| caption = Vancomycin-resistant ''Enterococcus'' under a microscope | |||
| field = [[Infectious disease]] | |||
| synonyms = VRE | |||
| symptoms = [[Urinary tract infection]], [[bacteremia]], [[endocarditis]], [[wound infection]] | |||
| complications = [[Sepsis]], [[multi-organ failure]] | |||
| onset = | |||
| duration = | |||
| causes = [[Enterococcus faecium]], [[Enterococcus faecalis]] | |||
| risks = [[Hospitalization]], [[antibiotic use]], [[immunocompromised]] | |||
| diagnosis = [[Culture (microbiology)|Culture]], [[antibiotic susceptibility testing]] | |||
| differential = | |||
| prevention = [[Infection control]], [[hand hygiene]] | |||
| treatment = [[Linezolid]], [[daptomycin]], [[tigecycline]] | |||
| medication = | |||
| prognosis = | |||
| frequency = | |||
| deaths = | |||
}} | |||
{{Short description|Bacterial strains resistant to the antibiotic vancomycin}} | {{Short description|Bacterial strains resistant to the antibiotic vancomycin}} | ||
[[File:Vancomycin-from-xtal-1996-3D-balls.png|left|thumb|3D structure of vancomycin]] | |||
[[File:Linezolid-from-xtal-2008-3D-balls.png|left|thumb|3D structure of linezolid]] | |||
'''Vancomycin-resistant Enterococcus''' ('''VRE''') refers to strains of the [[Enterococcus]] genus of bacteria that have developed resistance to the antibiotic [[vancomycin]]. These bacteria are significant in healthcare settings due to their ability to cause infections that are difficult to treat. | '''Vancomycin-resistant Enterococcus''' ('''VRE''') refers to strains of the [[Enterococcus]] genus of bacteria that have developed resistance to the antibiotic [[vancomycin]]. These bacteria are significant in healthcare settings due to their ability to cause infections that are difficult to treat. | ||
==Background== | ==Background== | ||
[[Enterococcus]] species are part of the normal flora of the human gastrointestinal tract but can cause serious infections, particularly in immunocompromised individuals. The development of resistance to [[vancomycin]], a last-resort antibiotic, poses a significant challenge in treating these infections. | [[Enterococcus]] species are part of the normal flora of the human gastrointestinal tract but can cause serious infections, particularly in immunocompromised individuals. The development of resistance to [[vancomycin]], a last-resort antibiotic, poses a significant challenge in treating these infections. | ||
==Mechanism of Resistance== | ==Mechanism of Resistance== | ||
VRE resistance to vancomycin is primarily due to the acquisition of the [[vanA]] or [[vanB]] gene clusters, which alter the target site of the antibiotic, reducing its binding affinity. This genetic alteration is often acquired through horizontal gene transfer. | VRE resistance to vancomycin is primarily due to the acquisition of the [[vanA]] or [[vanB]] gene clusters, which alter the target site of the antibiotic, reducing its binding affinity. This genetic alteration is often acquired through horizontal gene transfer. | ||
==Epidemiology== | ==Epidemiology== | ||
VRE infections are most commonly seen in hospital settings, particularly in patients with prolonged antibiotic use, those with weakened immune systems, or those undergoing invasive procedures. The prevalence of VRE varies globally, with higher rates reported in the United States and Europe. | VRE infections are most commonly seen in hospital settings, particularly in patients with prolonged antibiotic use, those with weakened immune systems, or those undergoing invasive procedures. The prevalence of VRE varies globally, with higher rates reported in the United States and Europe. | ||
==Clinical Significance== | ==Clinical Significance== | ||
VRE can cause a range of infections, including [[urinary tract infections]], [[bacteremia]], [[endocarditis]], and [[wound infections]]. These infections are associated with increased morbidity and mortality due to limited treatment options. | VRE can cause a range of infections, including [[urinary tract infections]], [[bacteremia]], [[endocarditis]], and [[wound infections]]. These infections are associated with increased morbidity and mortality due to limited treatment options. | ||
==Treatment== | ==Treatment== | ||
Treatment of VRE infections often involves the use of alternative antibiotics such as [[linezolid]] or [[daptomycin]]. However, the choice of treatment depends on the site of infection and the susceptibility profile of the isolate. | Treatment of VRE infections often involves the use of alternative antibiotics such as [[linezolid]] or [[daptomycin]]. However, the choice of treatment depends on the site of infection and the susceptibility profile of the isolate. | ||
==Prevention and Control== | ==Prevention and Control== | ||
Preventing the spread of VRE in healthcare settings involves strict adherence to infection control practices, including hand hygiene, use of personal protective equipment, and environmental cleaning. Screening and isolation of colonized or infected patients may also be necessary. | Preventing the spread of VRE in healthcare settings involves strict adherence to infection control practices, including hand hygiene, use of personal protective equipment, and environmental cleaning. Screening and isolation of colonized or infected patients may also be necessary. | ||
==See also== | |||
== | |||
* [[Antibiotic resistance]] | * [[Antibiotic resistance]] | ||
* [[Enterococcus]] | * [[Enterococcus]] | ||
* [[Vancomycin]] | * [[Vancomycin]] | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
[[Category:Antibiotic-resistant bacteria]] | [[Category:Antibiotic-resistant bacteria]] | ||
[[Category:Enterococcus]] | [[Category:Enterococcus]] | ||
Latest revision as of 00:09, 10 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Vancomycin-resistant Enterococcus | |
|---|---|
| |
| Synonyms | VRE |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Urinary tract infection, bacteremia, endocarditis, wound infection |
| Complications | Sepsis, multi-organ failure |
| Onset | |
| Duration | |
| Types | N/A |
| Causes | Enterococcus faecium, Enterococcus faecalis |
| Risks | Hospitalization, antibiotic use, immunocompromised |
| Diagnosis | Culture, antibiotic susceptibility testing |
| Differential diagnosis | |
| Prevention | Infection control, hand hygiene |
| Treatment | Linezolid, daptomycin, tigecycline |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Bacterial strains resistant to the antibiotic vancomycin
Vancomycin-resistant Enterococcus (VRE) refers to strains of the Enterococcus genus of bacteria that have developed resistance to the antibiotic vancomycin. These bacteria are significant in healthcare settings due to their ability to cause infections that are difficult to treat.
Background[edit]
Enterococcus species are part of the normal flora of the human gastrointestinal tract but can cause serious infections, particularly in immunocompromised individuals. The development of resistance to vancomycin, a last-resort antibiotic, poses a significant challenge in treating these infections.
Mechanism of Resistance[edit]
VRE resistance to vancomycin is primarily due to the acquisition of the vanA or vanB gene clusters, which alter the target site of the antibiotic, reducing its binding affinity. This genetic alteration is often acquired through horizontal gene transfer.
Epidemiology[edit]
VRE infections are most commonly seen in hospital settings, particularly in patients with prolonged antibiotic use, those with weakened immune systems, or those undergoing invasive procedures. The prevalence of VRE varies globally, with higher rates reported in the United States and Europe.
Clinical Significance[edit]
VRE can cause a range of infections, including urinary tract infections, bacteremia, endocarditis, and wound infections. These infections are associated with increased morbidity and mortality due to limited treatment options.
Treatment[edit]
Treatment of VRE infections often involves the use of alternative antibiotics such as linezolid or daptomycin. However, the choice of treatment depends on the site of infection and the susceptibility profile of the isolate.
Prevention and Control[edit]
Preventing the spread of VRE in healthcare settings involves strict adherence to infection control practices, including hand hygiene, use of personal protective equipment, and environmental cleaning. Screening and isolation of colonized or infected patients may also be necessary.
See also[edit]
References[edit]
<references group="" responsive="1"></references>
